Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2008Chemistry & BiologyOpen Access

Thienopyridone Drugs Are Selective Activators of AMP-Activated Protein Kinase β1-Containing Complexes

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJohn W. ScottFlorida Gulf Coast UniversityBDBryce J. W. van DenderenAustralian Regenerative Medicine InstituteSJSebastian B. JørgensenNovo Nordisk (Denmark)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Scott et al. (2008) studied this question.

synapsesocial.com/papers/6a8a7459754a5a619a723ff8https://doi.org/10.1016/j.chembiol.2008.10.005
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Roles of the Glycogen-binding Domain and Snf4 in Glucose Inhibition of SNF1 Protein Kinase2008 · 48 citations
  2. 25-Aminoimidazole-4-carboxamide 1-β- d -ribofuranoside (AICAR) stimulates myocardial glycogenolysis by allosteric mechanisms2003 · 142 citations
  3. 3Oligosaccharide recognition and binding to the carbohydrate binding module of AMP‐activated protein kinase2007 · 44 citations
  4. 4Crystal Structures of the Adenylate Sensor from Fission Yeast AMP-Activated Protein Kinase2007 · 176 citations
  5. 5Role of AMP-activated protein kinase in mechanism of metformin action2001 · 5,475 citations